Cell-based production of nonulosonates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9512455
SERIAL NO

14444622

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the cell-based production of bacterial nonulosonates and their biosynthetic precursors. Specifically, the present invention provides recombinant cells for the production of pseudaminic acid, legionaminic acid, UDP-2,4-diacetamido-2,4,6-trideoxy-□-L-altropyranose, and UDP-2,4-diacetamido-2,4,6-trideoxy-□-D-glucopyranose. Methods for producing the sugars are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF OTTAWA3042-800 KING EDWARD AVE SUITE 400 OTTAWA K1N 6N5

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boddy, Christopher N Ottawa, CA 6 12
Logan, Susan M Ottawa, CA 8 17
Lundgren, Benjamin R Nampa, US 7 5
Schoenhofen, Ian C Stittsville, CA 7 8
Whitfield, Dennis M Ottawa, CA 10 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00